The National Institutes of Health (NIH) spent $187 billion for basic or applied research related to 354 of the 356 drugs approved by the FDA from 2010 to 2019, according to a new study from Bentley University's Center for ...
Apr 28, 2023
0
76
A new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives were driven almost entirely by a type of treatment given to fewer than 1 in 5 patients. The study is published ...
Feb 27, 2023
0
2
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the share of promotional spending allocated to consumer advertising was on average 14.3 percentage points higher for drugs with ...
Feb 7, 2023
0
34
The U.S. government could save billions every year once Medicare begins negotiating drug prices in 2026, new research suggests.
Jan 30, 2023
0
0
A new study out of Brigham and Women's Hospital shows how newly marketed brand-name drugs in the U.S. are driving up health care spending, resulting in "detrimental effects for patient access and affordability."
Jun 8, 2022
0
1
The COVID-19 treatment remdesivir dominated hospital drug spending in 2021, accounting for nearly 10% of all pharmaceutical expenses and outpacing the next three drugs combined, according to the National Trends in Prescription ...
Apr 6, 2022
0
15
Medicare's "Part B" outpatient premium will jump by $21.60 a month in 2022, one of the largest increases ever. Officials said Friday a new Alzheimer's drug is responsible for about half of that.
Nov 12, 2021
0
4
Basing new drug launch prices on historical domestic data could limit manufacturers' power to set extremely high launch prices and could reduce Medicare spending on new drugs by up to 30%, according to a new white paper released ...
Sep 23, 2021
0
13
Prices for prescription drugs edged down by 1% last year, a rare result driven by declines for generics and slow, low growth in the cost of brand-name medications, the government said Thursday.
Dec 5, 2019
0
13
A new analysis of publicly reported financial data published today by researchers at West Health Policy Center and Johns Hopkins Bloomberg School of Public Health finds that large, brand-name drug manufacturers would still ...
Nov 14, 2019
1
1
